UPC_APP_16306/2025

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

Procedural & sub-applicationsWithdrawal ApplicationsDusseldorf LDApplication Rop 265—Settled at: Pre-merits

Parties

Claimants

GlaxoSmithKline Biologicals SA

Reps: Oliver Jan Jüngst (Bird & Bird LLP); Luca Brons (Bird & Bird LLP); Daniela Kinkeldey (Bird & Bird LLP); Anna Schadel (Bird & Bird LLP)

Respondents

Pfizer Europe MA EEIG
Pfizer Manufacturing Belgium NV
Pfizer Pharma GmbH
Pfizer Corporation Austria GmbH
Pfizer S.A.
Pfizer Aps
Pfizer Oy
Pfizer SAS
Pfizer S.r.l.
Pfizer B.V.
Laboratórios Pfizer, Lda.
Pfizer AB
Pfizer Luxembourg S.a.r.l.
Pfizer Service Company S.R.L.

Reps: Gareth Williams (Marks & Clerk LLP); Claudia Milbradt (Clifford Chance Partnerschaft mbB); Tobias J. Hessel (Clifford Chance Partnerschaft mbB)

Judges

ThomasPresiding Judge
SchumacherJudge-Rapporteur / Legally Qualified Judge
PostiglioneLegally Qualified Judge
Wadskov-HansenTechnically Qualified Judge

Patents

EP4183412

CPC codes: C12N2760/18522, C12N2760/18534, A61K2039/55505, A61K2039/5258, A61K2039/55566, A61K39/155, A61K39/12, C07K2319/73, A61K2039/53, C07K2317/76, A61P31/14, A61P37/04…

Sector: Biotechnology

Outcome

Withdrawn

Filed: —

First decided: Apr 11, 2025

Language: —

Settled at: Pre-merits — settled commercially

The Düsseldorf Local Division allowed GlaxoSmithKline Biologicals SA's withdrawal of its infringement action against Pfizer entities concerning EP 4 183 412 with the consent of all defendants, declared the proceedings closed, and ordered reimbursement of 60% of court fees amounting to EUR 201,600.